Morning Market Gainers By: Benzinga via Benzinga February 13, 2015 at 09:45 AM EST Cytokinetics, Incorporated (NASDAQ: CYTK) shares climbed 18.46% to $7.69 on Q4 results. Cytokinetics reported Q4 earnings of $8.4 ... Read More >> Related Stocks: CBS Corp Columbia Sprtswr Cyberark Soft Ord Cytokinetics J2 Global Inc King Digital Rocky Brands Inc